Relation Therapeutics Inc. is an active for-profit biotechnology company founded in 2019 that focuses on therapeutic development.
Subscribe to see Relation Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Relation Therapeutics Inc. is a biotech company headquartered in United States. It has raised at least $151.4M across the 6 funding rounds on record. Its most recent funding round raised $36.2M in November 2025. Xcout tracks 23 named people at Relation Therapeutics Inc., including David Roblin (Chief Executive Officer). Xcout recorded 16 job postings from Relation Therapeutics Inc. in the last 90 days, naming tools such as PyTorch, Jira.
17 more named people on record for Relation Therapeutics Inc., with roles, board committees and tenure — see the full roster →
At least $151.4M raised across the 6 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $36.2M | — | |
| SEC Form D filing | $15M | — | |
| Seed | $35M | 3 named | |
| Seed | $40.3M | 3 named | |
| SEC Form D filing | $16M | — | |
| SEC Form D filing | $9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 16 job postings from Relation Therapeutics Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Relation Therapeutics Inc.'s hiring signals →
A few of Relation Therapeutics Inc.'s closest competitors — see the full list of competitors and alternatives →
Cellarity is a U.S. biotechnology company that uses single-cell biology, computational modeling, and machine learning to discover medicines based on cellular behaviors and disease mechanisms. It serves pharmaceutical and biotechnology development needs, advancing its own therapeutic programs and potentially partnering with other drug developers.
Modulus Therapeutics, Inc. is a research and development business services company located in Washington state, focusing on therapeutic innovations.
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Genesis Therapeutics, Inc. is an active for-profit biotechnology company founded by Ben Sklaroff and Evan Feinberg. The company specializes in leveraging artificial intelligence for molecular discovery and drug development with operations in California and Delaware.
NeuroX1 Inc. is a for-profit biotechnology startup founded in 2021 with headquarters in Austin, Texas, operating a target identification and drug discovery platform that utilizes proprietary technology.
GATC Health Corp. is a biotechnology company that uses artificial intelligence, genomics, and toxicology data to discover and develop therapeutics and predict drug safety. Its work is aimed at pharmaceutical and biotechnology partners as well as patients needing treatments for serious diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.